Humana Statistics
Total Valuation
Humana has a market cap or net worth of $34.15 billion. The enterprise value is $41.71 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 11, 2026, before market open.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | Dec 26, 2025 |
Share Statistics
Humana has 120.27 million shares outstanding. The number of shares has decreased by -0.55% in one year.
| Current Share Class | 120.27M |
| Shares Outstanding | 120.27M |
| Shares Change (YoY) | -0.55% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 97.06% |
| Float | 120.03M |
Valuation Ratios
The trailing PE ratio is 26.58 and the forward PE ratio is 20.86. Humana's PEG ratio is 3.43.
| PE Ratio | 26.58 |
| Forward PE | 20.86 |
| PS Ratio | 0.27 |
| Forward PS | 0.24 |
| PB Ratio | 1.84 |
| P/TBV Ratio | 4.45 |
| P/FCF Ratio | 22.08 |
| P/OCF Ratio | 16.70 |
| PEG Ratio | 3.43 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.80, with an EV/FCF ratio of 26.96.
| EV / Earnings | 32.31 |
| EV / Sales | 0.33 |
| EV / EBITDA | 10.80 |
| EV / EBIT | 11.42 |
| EV / FCF | 26.96 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.70.
| Current Ratio | 2.02 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | 8.37 |
| Interest Coverage | 5.63 |
Financial Efficiency
Return on equity (ROE) is 7.16% and return on invested capital (ROIC) is 7.30%.
| Return on Equity (ROE) | 7.16% |
| Return on Assets (ROA) | 4.58% |
| Return on Invested Capital (ROIC) | 7.30% |
| Return on Capital Employed (ROCE) | 10.89% |
| Revenue Per Employee | $1.92M |
| Profits Per Employee | $19,656 |
| Employee Count | 65,680 |
| Asset Turnover | 2.53 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $283.00 million in taxes.
| Income Tax | 283.00M |
| Effective Tax Rate | 17.92% |
Stock Price Statistics
The stock price has increased by +0.47% in the last 52 weeks. The beta is 0.46, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +0.47% |
| 50-Day Moving Average | 255.62 |
| 200-Day Moving Average | 259.12 |
| Relative Strength Index (RSI) | 66.65 |
| Average Volume (20 Days) | 905,631 |
Short Selling Information
The latest short interest is 5.30 million, so 4.40% of the outstanding shares have been sold short.
| Short Interest | 5.30M |
| Short Previous Month | 4.78M |
| Short % of Shares Out | 4.40% |
| Short % of Float | 4.41% |
| Short Ratio (days to cover) | 3.85 |
Income Statement
In the last 12 months, Humana had revenue of $126.36 billion and earned $1.29 billion in profits. Earnings per share was $10.68.
| Revenue | 126.36B |
| Gross Profit | 18.89B |
| Operating Income | 3.65B |
| Pretax Income | 1.58B |
| Net Income | 1.29B |
| EBITDA | 3.86B |
| EBIT | 3.65B |
| Earnings Per Share (EPS) | $10.68 |
Full Income StatementBalance Sheet
The company has $22.12 billion in cash and $12.95 billion in debt, with a net cash position of -$7.56 billion or -$62.87 per share.
| Cash & Cash Equivalents | 22.12B |
| Total Debt | 12.95B |
| Net Cash | -7.56B |
| Net Cash Per Share | -$62.87 |
| Equity (Book Value) | 18.58B |
| Book Value Per Share | 154.00 |
| Working Capital | 16.57B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.05 billion and capital expenditures -$498.00 million, giving a free cash flow of $1.55 billion.
| Operating Cash Flow | 2.05B |
| Capital Expenditures | -498.00M |
| Free Cash Flow | 1.55B |
| FCF Per Share | $12.86 |
Full Cash Flow StatementMargins
Gross margin is 14.95%, with operating and profit margins of 2.89% and 1.02%.
| Gross Margin | 14.95% |
| Operating Margin | 2.89% |
| Pretax Margin | 1.25% |
| Profit Margin | 1.02% |
| EBITDA Margin | 3.06% |
| EBIT Margin | 2.89% |
| FCF Margin | 1.22% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.25%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 33.14% |
| Buyback Yield | 0.55% |
| Shareholder Yield | 1.80% |
| Earnings Yield | 3.78% |
| FCF Yield | 4.53% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $290.35, which is 2.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $290.35 |
| Price Target Difference | 2.25% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 9.01% |
| EPS Growth Forecast (5Y) | 25.23% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
